Evans Blue Dye (EBD) is widely used to study cellular membrane permeability and has recently been utilised in mdx mice to identify permeable skeletal myofibres that have become damaged as a result of muscular dystrophy. EBD has the potential to be a useful vital stain of myofibre permeability in other models of skeletal muscle injury and membrane-associated fragility. The parameters for its use for such purposes were optimised in the present study.
Introduction
Evans Blue Dye ) is widely used to study blood vessel and cellular membrane permeability as it is non-toxic, it can be administered as an intravital dye and it binds to serum albumin -using this as its transporter molecule. The EBD-albumin conjugate (EBA) can be: (i) identified macroscopically by the striking blue colour within tissue (Matsuda et al. 1995);  (ii) observed by red auto-fluorescence in tissue sections examined by fluorescence microscopy (Matsuda et al. 1995; Brussee et al. 1997; Tidball et al. 1999); and (iii) assessed and quantified by spectrophotometry for serum samples (Brown et al. 1992) , or homogenised tissue (Oztas et al. 1992) .
Recently, EBD has been used in mdx mice to identify damaged skeletal myofibres that had become permeable owing to muscular dystrophy (Matsuda et al. 1995; Brussee et al. 1997) . The mdx mouse is an animal model for human Duchenne's Muscular Dystrophy (DMD), which is an X chromosome-linked disorder characterised by progressive muscle degeneration and weakness. Matsuda et al. (1995) injected EBD into the tail vein of mdx mice and demonstrated that myofibres that contained EBD were identifiable, via haematoxylin and eosin (H&E) staining, as swollen or hypercontracted. Brussee et al. (1997) also injected EBD into the tail vein of mdx and C57Bl mice in their examination of the fragility of the dystrophic muscle during downhill running on a treadmill, and they similarly observed that the auto-fluorescent fibres showed evidence of hypercontraction or degeneration. In marked contrast to the mdx mouse there was little penetration of EBD in other myopathies resulting from defects in the laminin α -2 chain (Straub et al. 1997) . The intensity of EBD fluorescence has been used to identify mechanically induced damage to skeletal muscle in a suspension-reloading model of muscle injury (Tidball et al. 1999) .
Despite the wide use of EBD as an in vivo marker of plasma membrane permeability, there has been no and (iii) exercise-induced muscle damage.
Materials and methods

Animals
Adult, 6-to 12-week-old, normal control C57Bl/10ScSn
(hereafter referred to as C57Bl), BALB/c, and dystrophic mdx male mice were used in these experiments. Mice 
Animal preparation
Mice were anaesthetised by inhalation of a gaseous mixture of halothane (Fluothane, Zeneca) and nitrous oxide (BOC Gases, Perth) in oxygen (0.5 L min -1 haloth-
Mode of injection of Evans Blue Dye
Mice were injected with 1% EBD (Sigma, St Louis, MO, USA) (w/v) in phosphate-buffered saline (PBS, pH 7.5) sterilised by passage through a Millex®-GP 0.22 µ m filter (Millipore, Bedford, MA, USA) and stored at 4 ° C.
Intravenous (i.v.) injections were made to either of the dorsal veins of the tail. Intraperitoneal (i.p.)
injections were made into the right side of the peritoneal cavity. After injection, animals were returned to their cage and allowed food and water ad libitum .
Methods of tissue fixation
In experiments in which fresh frozen tissue was required, anaesthetised mice were killed by cervical dislocation, the tibialis anterior (TA) and extensor digitorum longus (EDL) muscles of the hind limbs were removed, and sliced transversely at the maximum diameter, mounted vertically in tragacanth gum (Sigma) on cork blocks and snap frozen in isopentane, cooled by liquid nitrogen, and stored at -80 ° C. In some experiments mice were perfused, via a cannula inserted into the left ventricle of the heart, with 50 mL of PBS containing 0.1% heparin (David Bull Laboratories, Melbourne, Australia) followed by 50 mL of freshly prepared 4% (w/v) paraformaldehyde (PFA) (Merck, Dermstadt, Germany) in PBS (pH 7.5). The TA and EDL muscles were removed and frozen as previously described.
In other experiments in which tissues were fixed by immersion, the complete hindlimbs were immersed in freshly prepared 4% PFA (pH 7.5) for 3 h. Subsequently, the TA and EDL muscles were removed from the limbs and processed for paraffin embedding. Comparison of the efficacy of various fixatives was examined in muscle tissue samples that had been immersed in either 10% buffered formal saline (BFS), 4% PFA or cold 95%
ethanol for 3 h.
Histochemistry and fluorescent imaging
Frozen sections (10 µ m) were cut at -21 ° C on a Leica (CM3050) cryostat, dipped in cold acetone (-20 ° C) for 1 min and then air-dried at room temperature 
Viewing and imaging
The H&E-stained muscle sections were viewed with bright-field light microscopy, whereas the unstained 
Immunohistochemistry
Direct detection of serum albumin by an antibody would avoid the need for pre-injection of EBD and ideally would be carried out on paraffin sections in which morphology is consistently superior to frozen sections. Subsequently, anti-rat serum albumin (ICN Aurora, OH, USA) conjugated to horseradish peroxidase (HRP) was used to visualise serum albumin in frozen and paraffin sections (McNeil & Khakee, 1992) .
Defining parameters for the use of EBD
Mode of injection
To compare i.v. with i.p. injection of EBD, four mdx mice (20 ± 2 g) were injected with a solution of 1%
EBD at a volume of 1% of body mass (BM) 1 mg EBD/0.1 mL PBS/10 gBM (Matsuda et al. 1995) , referred to subsequently as the standard 1% EBD. Two mice were injected via i.v. and two via an i.p. route. One of each pair was killed at 7 h and 24 h after injection, respectively. The TA and EDL muscles were prepared for frozen sections.
Fixation
To compare fixed vs. frozen tissues, one mdx mouse (26 g) was injected i.p. with the standard 1% EBD 24 h before being killed. The TA muscles were removed, cut transversely, and 10 serial sections for each condition were fixed in either: 4% PFA, 10% BFS, cold (-20 ° C) 95% ethanol, or snap frozen in isopentane.
Volume of EBD
The aim of this experiment was to determine whether 
Experimental muscle damage
The optimal conditions were defined from the above studies (1% EBD at 1% BM injected i.p. 16-24 h before sampling, henceforth referred to as 1% EBD), and applied to three experimental muscle injuries.
Cut injury
This experiment, using a cut injury to 'normal' muscle, was designed to demonstrate (i) how rapidly EBD would be detected within damaged myofibres after a known injury; and (ii) the penetration of EBD along the length of damaged myofibres (before resealing occurs).
Nine C57Bl mice had a single transverse cut injury made in the mid-region of the left TA, as described by Grounds et al. (1992) 
Whole muscle grafts
To test whether EBD could label damaged myofibres in an avascular muscle graft, four BALB/c mice (20 g) received an autograft of intact whole EDL muscle as described by Roberts et al. (1989) . Immediately (time 0) and at 1, 2 and 7 days after surgery one mouse was injected i.p. with 1% EBD. Mice were killed 1 day after EBD injection and muscles fixed with different protocols as detailed in Table 1 .
Exercise-induced muscle damage
The permeability of muscle fibres as a result of mild exercise-induced damage was investigated following controlled lengthening-contractions of the TA and EDL muscles (Armstrong et al. 1991; Faulkner & Brooks, 1994) . Three C57Bl mice (25 g) were assessed for muscle performance on a custom-made servo-controlled mouse dynamometer that controlled angular displacement, velocity and acceleration of the ankle joint (Hamer et al. 1998 ) while the exposed common peroneal nerve was directly stimulated via needle electrodes connected to a Grass™ S-88 stimulator. Torque generated by the anterior crural muscles (TA, EDL, and Extensor
Hallucis Longus) about the ankle joint axis was recorded from an axial torque transducer placed in-line with the axis of the servomotor (Hamer et al. 1998 ).
The neutral position of the ankle, defined as 0 ° , was with the foot perpendicular to the tibia. 
Results
Defining optimal parameters
Mode of injection
Similar intensity of the red auto-fluorescent EBD signal was seen within myofibres and in the surrounding interstitium in mdx mice in which EBD was injected i.v. injection was the method of choice for future experiments. EBD was occasionally seen in myofibres that had a relatively normal histological appearance in H&E-stained sections (compare Fig. 1a and b) , indicating that EBD has greater sensitivity than H&E staining for the detection of mildly damaged myofibres.
Fixation
Muscles from mdx mice that had been fixed (in 4% PFA, 
Volume of EBD injected
Injections of different volumes of EBD relative to body mass showed that a 0.5% volume (of a 1% EBD solution) did label permeable myofibres and the interstitium, but the signal strength was greater with a 1%
injection volume (i.e. 0.25 mL/25 g mouse). The 2.5%
relative volume gave no greater labelling of myofibres, but the interstitium and endothelial walls of blood vessels gave greater signal intensity. In control C57Bl mice injected i.p. with the 2.5% volume of EBD 24 h prior to being killed, strong EBD labelling occurred in the interstitium but no EBD was evident within the myofibres (data not shown). Therefore, injection of a 1% volume of EBD relative to body mass was used in all further studies.
Persistence of EBD within permeable myofibres
The presence of EBD in frozen sections of muscle from mdx mice that had been injected with EBD at various times prior to sampling was semi-quantified with the use of a Likert seven-point scale (see Methods) in which 6 indicates stronger signal. Graphical representation of the score obtained across these times for the EBD signal in the myofibre and interstitium is presented in Fig. 2. A greater difference in scores represents a greater contrast between the fluorescent signal in myofibres and the interstitium. The greatest contrast occurred when EBD was injected at 24 and 16 h before tissue sampling (Fig. 2) . Useful contrast was still evident when EBD was injected up to 4 days and as little as 8 h before sampling (Fig. 2) . Sections of two control (uninjured) C57Bl mice that were injected with 1% EBD at 4 and 1 day prior to being killed showed no EBD within myofibres, although signal was evident in the interstitium.
Experimental muscle damage
Cut injury
To investigate the penetration of EBD along the length of injured myofibres, an i.p. injection of 1% EBD was is shown in the transverse sections in Fig. 3(b-f) .
Some EBD could be detected in myofibres around 150 µ m proximal to the cut-injured site (Fig. 3b) , but there was little signal beyond this (not shown). EBD increased dramatically at 50 µ m proximal (Fig. 3c) ,
and was distinct at 0 µ m (Fig. 3d) , i.e. closest to the cut-injured site. The EBD signal diminished with distance but was still readily detectable at 100 µ m distal to the cut-injured site (Fig. 3e) . 
Whole muscle grafts
Transplantation of a whole EDL muscle graft results in complete disruption to all vascular supply to the EDL but no direct damage to the structure of the muscle fibres. Permeability to EBD throughout all myofibres of the graft (Fig. 4a ) was apparent within 1 day (EBD injected at time 0) and this was maintained for up to a week. To confirm that newly formed myotubes in the graft excluded EBD, one mouse was injected i.p. with 1% EBD at 7 days after grafting (when the necrotic muscle has been replaced by myotubes) and the mouse killed 1 day later (Day 8). The new myotubes were devoid of EBD (Fig. 4b) , and EBD was predominantly seen in new blood vessels of the graft and persisting necrotic muscle tissue, as well as some labelling of interstitium and surrounding epimysium.
Exercise-induced muscle damage
TA muscles of C57Bl mice were subjected to lengtheningcontraction exercise 18 h after EBD injection, and were sampled at 20 and 60 min after completion of the exercise. EBD was present in myofibres as early as 20 min after exercise (Fig. 5b) . The EBD-positive myofibres at 1 h after exercise also appeared to be swollen (Fig. 5c ).
The non-exercised control muscle (Fig. 5a ), as well as much of the exercised muscle ( Fig. 5b-d) , showed no evidence of EBD within myofibres. Figure 5 (e) shows the mean peak torque achieved during a tetanic isometric contraction at the optimal angle for torque production, for the anterior crural muscles of three mice sampled 20 and 60 min after exercise. These data show that, after the 20 lengthening-contractions, there was a 30% reduction in torque production by 20 min and a further reduction by 1 h to a value of 62% of the pre-exercise torque. By 3 days after exercise, Fig. 3 Distribution of EBD after cut injury in TA muscle of a C57Bl mouse shown in transverse frozen sections (10 µm). The locality of the section levels (b -e) relative to the site of cut injury is depicted in (a). 1% EBD was injected immediately after injury and muscle sampled after 20 h. Inverted greyscale images (b to e) demonstrate the distribution of EBD distant from, and at, the site of damage (dark coloured regions). An H&E-stained section (f), obtained from close to level D (at the injury site), demonstrates inflammatory infiltrate and destruction of tissue with normal morphology in adjacent myofibres (*).
torque production had recovered to 87% of the pre-exercise value (Fig. 5e) . Furthermore, at 3 days after exercise, few EBD-positive myofibres were present and the intensity of EBD signal within any myofibres was quite weak (Fig. 5d ). (Tidball et al. 1999 ). While standard precautions should be taken to prepare and store sections in reduced light conditions to avoid photo-bleaching, this appears not to be critical. Slides stored at room temperature in covered slide trays have been viewed 12 months after initial viewing, with EBD signal still very evident and able to be analysed.
Discussion
Other models used to examine membrane permeability in damaged muscle have included: Procion Orange as a vital stain for myofibres in mdx mice (Pagel & Partridge, 1999) ; antibody to serum albumin after mechanical loading injury of the myocardium (Clarke et al. 1995) ; and lysine fixable fluorescein dextran (~10 kDa MW) (FdxLys) after lengthening-contractions of skeletal muscle (McNeil & Khakee, 1992) . The results of the present study show that EBD provides a more sensitive method of detection than an antibody to 
Experimental use of EBD
The use of EBD as an in vivo marker of myofibre permeability facilitates the investigation of the effect of The mean (± SD) peak torque, recorded from the final 50 ms of three repeated 150-ms maximal isometric contractions (at optimal voltage, angle and frequency) in three C57Bl mice, before and after exercise at various times shows the deficit after exercise, and recovery towards pre-exercise values by 3 days.
pathology, muscle injury, and exercise on instantaneous and/or sustained permeability of skeletal myofibres.
The present study confirms that the EBD technique is highly sensitive and is able to detect permeable myofibres in mouse muscle affected by muscular dystrophy ( mdx ) that were not detected by standard histological techniques, e.g. H&E staining. Matsuda et al. (1995) and Pagel & Partridge (1999) (Warren et al. 1999) . Evidence of damage to sarcomeres has been observed with the use of electron microscopy, within 1 h following lengtheningcontraction exercise (Fridén et al. 1983 ) and immunohistochemistry has shown loss of desmin within 1 h of completion of lengthening-contraction exercise (Fridén & Lieber, 1994) . Additional studies are in progress to determine the earliest times when damage can be detected after exercise and what extent of damage is required for the subsequent breakdown (necrosis) of myotubes. The relatively lower numbers of myofibres containing EBD 3 days after the exercise is probably accounted for by resealing of damaged myofibres before the EBD injection. Since resealing of necrotic myofibres occurs by 12 h and is completed by 24 h after injury (Papadimitriou et al. 1990 ), when EBD was injected at 2 days (and muscle sampled at 3 days), the EBD would have been excluded from the resealed portions of the previously permeable myofibres. Alternatively, it is possible that much of the damage seen at 20 min does not result in necrosis (followed by regeneration) of myofibres. Instead the permeable sarcolemma may be locally repaired, thus preventing breakdown of the myofibre (Grounds, 1998; Togo et al. 1999 ). Such rapid local membrane repair (McNeil & Terasaki, 2001 ) would result in reduced damage being detectable in muscles injected after exercise at 2 days with EBD, and sampled at 3 days. Techniques, such as the use of nitroblue tetrazolium (Tang et al. 1998) , to assess the viability of the EBD-positive myofibres may be useful to determine whether changes in the in vivo myofibre permeability detected by EBD commit the myofibre to cell death. Detailed analysis of muscle samples, for evidence of muscle cell death and regeneration at various times after exercise, should resolve this situation and such studies are in progress in our laboratory. The apparent improvement in structural integrity at 3 days was also accompanied by a reduced torque deficit when compared with the torque recorded 10 min after the initial damaging exercise.
The deficit in torque production immediately following the initial bout of exercise and the return of muscle torque production over time observed in the present experiment are consistent with the published literature (for review see Warren et al. 1999 ) that report that the decrease in muscle function is greatest immediately after the damaging exercise and progressively returns to normal over a 10-day period.
The value of the EBD technique as a simple and sensitive vital marker of early muscle damage lies in its sensitivity to detect instantaneous and/or sustained changes in permeability of sublethal myofibre injury.
The technique is being used in further studies to assess the thresholds of muscle damage in myopathic and normal muscles subjected to various exercise regimes.
